Oruka Therapeutics, Inc.
ORKA NASDAQHealthcare ★★★★★Latest Earnings
Date
Aug 10, 2026
ET
EPS Est.
-0.51
EPS Actual
-0.55
Revenue Est.
--
Revenue Actual
--
Next Earnings Report Date unconfirmed
Date
Nov 11, 2026 · Wed
Time
Time TBD
Fiscal Period
FY2026 Q3
EPS Est.
-0.59
Revenue Est.
--
Company Overview
Oruka Therapeutics, Inc. (ticker ORKA) is listed on NASDAQ with a market cap of about $6.51B. Its next earnings report (FY2026 Q3) is expected on Nov 11, 2026 (ET), Time TBD (date pending company confirmation), with consensus EPS of -0.59. In the last 8 reported quarters, EPS beat consensus estimates 6 times.
Actual EPS TrendRecently15Term · Dec 31, 2022 → Aug 10, 2026
Dec 31, 2022Range: -1.46 ~ -0.08Aug 10, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 10, 2026 | -- | -0.51 | -0.55 | -- | -- |
| May 13, 2026 | -- | -0.55 | -0.48 | -- | -- |
| Mar 12, 2026 | -- | -0.61 | Above forecast↑-0.45 | -- | -- |
| Nov 12, 2025 | -- | -0.56 | -0.55 | -- | -- |
| Aug 11, 2025 | -- | -0.48 | -0.46 | -- | -- |
| May 14, 2025 | -- | -0.57 | Above forecast↑-0.40 | -- | -- |
| Mar 6, 2025 | -- | -0.68 | Above forecast↑-0.49 | -- | -- |
| Nov 13, 2024 | -- | -0.40 | Below forecast↓-1.46 | -- | -- |
| Aug 1, 2024 | -- | -- | -0.76 | -- | -- |
| Apr 25, 2024 | -- | -- | -0.14 | -- | -- |
| Dec 31, 2023 | -- | -- | -0.08 | -- | -- |
| Sep 30, 2023 | -- | -- | -0.10 | -- | -- |
| Jun 30, 2023 | -- | -- | -0.10 | -- | -- |
| Mar 31, 2023 | -- | -- | -0.09 | -- | -- |
| Dec 31, 2022 | -- | -- | -0.98 | -- | -- |
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
